VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang
VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
Market Cap & Net Worth: VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang (VX1)
VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang (DU:VX1) has a market capitalization of $4.25 Million (€4.14 Million) as of March 19, 2026. Listed on the DU stock exchange, this Germany-based company holds position #31813 globally and #3532 in its home market, demonstrating a 2.44% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang's stock price €419.75 by its total outstanding shares 9862 (9.86K).
VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang Market Cap History: 2015 to 2026
VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang's market capitalization history from 2015 to 2026. Data shows growth from $1.18 Million to $4.25 Million (14.80% CAGR).
VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang's market cap is 0.00 times its annual earnings
0.00x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $712.77K | $1.70 Billion | -$112.05 Million | 0.00x | N/A |
| 2017 | $1.28 Million | $2.49 Billion | $263.48 Million | 0.00x | 0.00x |
| 2018 | $1.44 Million | $3.05 Billion | $2.10 Billion | 0.00x | 0.00x |
| 2019 | $1.99 Million | $4.16 Billion | $1.18 Billion | 0.00x | 0.00x |
| 2020 | $1.92 Million | $6.21 Billion | $2.71 Billion | 0.00x | 0.00x |
| 2021 | $1.99 Million | $7.57 Billion | $2.34 Billion | 0.00x | 0.00x |
| 2022 | $2.72 Million | $8.93 Billion | $3.32 Billion | 0.00x | 0.00x |
| 2023 | $3.75 Million | $9.87 Billion | $3.62 Billion | 0.00x | 0.00x |
Competitor Companies of VX1 by Market Capitalization
Companies near VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang in the global market cap rankings as of March 19, 2026.
Key companies related to VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang Historical Marketcap From 2015 to 2026
Between 2015 and today, VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang's market cap moved from $1.18 Million to $ 4.25 Million, with a yearly change of 14.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €4.25 Million | +7.49% |
| 2025 | €3.95 Million | +0.23% |
| 2024 | €3.94 Million | +5.28% |
| 2023 | €3.75 Million | +37.77% |
| 2022 | €2.72 Million | +36.58% |
| 2021 | €1.99 Million | +3.72% |
| 2020 | €1.92 Million | -3.58% |
| 2019 | €1.99 Million | +38.50% |
| 2018 | €1.44 Million | +12.62% |
| 2017 | €1.28 Million | +79.05% |
| 2016 | €712.77K | -39.40% |
| 2015 | €1.18 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of VERTEX PHARMACEUTIC - Dusseldorf Stock Exchang was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.25 Million USD |
| MoneyControl | $4.25 Million USD |
| MarketWatch | $4.25 Million USD |
| marketcap.company | $4.25 Million USD |
| Reuters | $4.25 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.